SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 96 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $119,595 | -47.3% | 134,983 | -6.6% | 0.00% | -100.0% |
| Q3 2022 | $227,000 | -21.7% | 144,483 | +0.2% | 0.00% | 0.0% |
| Q2 2022 | $290,000 | -22.9% | 144,233 | -10.5% | 0.00% | 0.0% |
| Q1 2022 | $376,000 | -45.7% | 161,195 | +8.2% | 0.00% | 0.0% |
| Q4 2021 | $693,000 | -57.8% | 148,931 | -30.8% | 0.00% | -66.7% |
| Q3 2021 | $1,642,000 | -11.0% | 215,161 | +13.1% | 0.00% | -25.0% |
| Q2 2021 | $1,844,000 | +24.3% | 190,254 | +6.1% | 0.00% | +33.3% |
| Q1 2021 | $1,483,000 | +50.4% | 179,336 | +24.1% | 0.00% | +50.0% |
| Q4 2020 | $986,000 | -62.8% | 144,522 | -39.2% | 0.00% | -75.0% |
| Q3 2020 | $2,648,000 | +633.5% | 237,528 | +312.9% | 0.01% | +700.0% |
| Q2 2020 | $361,000 | +1469.6% | 57,523 | +357.4% | 0.00% | – |
| Q1 2020 | $23,000 | -36.1% | 12,577 | +19.5% | 0.00% | – |
| Q4 2019 | $36,000 | +33.3% | 10,527 | -15.5% | 0.00% | – |
| Q3 2019 | $27,000 | -18.2% | 12,459 | 0.0% | 0.00% | – |
| Q2 2019 | $33,000 | -44.1% | 12,459 | 0.0% | 0.00% | – |
| Q1 2019 | $59,000 | – | 12,459 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Oaktree Fund Advisors, LLC | 66,000 | $503,000 | 48.93% |
| SABBY MANAGEMENT, LLC | 1,698,107 | $12,957,000 | 1.75% |
| EMFO, LLC | 233,008 | $1,778,000 | 1.57% |
| swisspartners Ltd. | 110,000 | $839,000 | 0.65% |
| HERITAGE WEALTH MANAGEMENT, LLC | 150,000 | $1,145,000 | 0.41% |
| Donald L. Hagan, LLC | 42,929 | $328,000 | 0.19% |
| COLLECTIVE FAMILY OFFICE LLC | 44,203 | $337,000 | 0.14% |
| Spectrum Wealth Advisory Group, LLC | 18,093 | $138,000 | 0.14% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 100,000 | $763,000 | 0.13% |
| Cormorant Asset Management, LP | 400,000 | $3,052,000 | 0.12% |